Literature DB >> 7693904

Treatment with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type Ib.

A Lachaux1, O Boillot, D Stamm, I Canterino, C Dumontet, F Regnier, D Floret, M Hermier.   

Abstract

A 7 1/2-year-old patient with glycogenosis type lb had chronic neutropenia, recurrent bacterial infections, and severe hypoglycemia in spite of continuous nasogastric feeding. She was treated with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation. Absolute neutrophil counts and platelet counts rapidly reached normal values, and infectious episodes were reduced. She resumed oral feeding after transplantation and had no subsequent hypoglycemic episodes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693904     DOI: 10.1016/s0022-3476(05)80403-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  The gene for glycogen-storage disease type 1b maps to chromosome 11q23.

Authors:  B Annabi; H Hiraiwa; B C Mansfield; K J Lei; T Ubagai; M H Polymeropoulos; S W Moses; R Parvari; E Hershkovitz; H Mandel; M Fryman; J Y Chou
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

Review 2.  Gene therapy for type I glycogen storage diseases.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Curr Gene Ther       Date:  2007-04       Impact factor: 4.391

3.  Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice.

Authors:  W H Yiu; C-J Pan; M Allamarvdasht; S Y Kim; J Y Chou
Journal:  Gene Ther       Date:  2006-09-28       Impact factor: 5.250

Review 4.  Congenital neutropenia: diagnosis, molecular bases and patient management.

Authors:  Jean Donadieu; Odile Fenneteau; Blandine Beaupain; Nizar Mahlaoui; Christine Bellanné Chantelot
Journal:  Orphanet J Rare Dis       Date:  2011-05-19       Impact factor: 4.123

5.  Quantitative analysis of glucose-6-phosphate translocase gene expression in various human tissues and haematopoietic progenitor cells.

Authors:  K Ihara; A Nomura; S Hikino; H Takada; T Hara
Journal:  J Inherit Metab Dis       Date:  2000-09       Impact factor: 4.982

Review 6.  Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings.

Authors:  J E Frampton; Y E Yarker; K L Goa
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

7.  Improved neutrophil function in a glycogen storage disease type 1b patient after liver transplantation.

Authors:  Masanori Adachi; Masato Shinkai; Youkatsu Ohhama; Katsuhiko Tachibana; Tadatoshi Kuratsuji; Hiroh Saji; Etsuko Maruya
Journal:  Eur J Pediatr       Date:  2004-02-11       Impact factor: 3.183

Review 8.  Neutropenia in type Ib glycogen storage disease.

Authors:  Janice Y Chou; Hyun S Jun; Brian C Mansfield
Journal:  Curr Opin Hematol       Date:  2010-01       Impact factor: 3.284

Review 9.  Liver transplantation in glycogen storage disease type I.

Authors:  Susanna J B Boers; Gepke Visser; Peter G P A Smit; Sabine A Fuchs
Journal:  Orphanet J Rare Dis       Date:  2014-04-09       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.